Can targeting the RAS signalling pathway change pancreatic cancer treatment?
Explore how Daraxonrasib (RMC-6236 / RASONQUE) works, its molecular mechanism, KRAS mutations, clinical trial findings, FDA approval, and its significance in targeted cancer therapy.
๐ฅ ๐พ๐๐๐๐: https://youtu.be/bNlUXz9EnQM
#Daraxonrasib #PancreaticCancer #RASONQUE #KRAS #RASInhibitor #CancerResearch #MolecularBiology #TargetedTherapy #MedicalScience #PrecisionMedicine
